Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2022 年第 4 季持倉
持倉截至 2022/12/31，2023/2/14 申報。只含多頭部位，變化是跟 2022 年第 3 季比股數。
- 持股檔數
- 84
- 較 2022 年第 3 季 −12
- 總值
- $42.8 億
- 較 2022 年第 3 季 −$3.19 億 (−6.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 625,000 | $2.37 億 | 5.5% | +133,200+27.1% | 加碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 785,500 | $2.18 億 | 5.1% | −184,700−19.0% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 1,780,000 | $2.13 億 | 5.0% | −75,700−4.1% | 減碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 3,825,000 | $2.10 億 | 4.9% | +703,000+22.5% | 加碼 | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 2,953,000 | $1.78 億 | 4.2% | +986,000+50.1% | 加碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 4,950,000 | $1.69 億 | 4.0% | +606,500+14.0% | 加碼 | 歷史 |
| BSXBoston Scientific Corp | Stock | 3,256,700 | $1.51 億 | 3.5% | +718,100+28.3% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 5,861,000 | $1.49 億 | 3.5% | +274,100+4.9% | 加碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 2,990,000 | $1.39 億 | 3.2% | +938,400+45.7% | 加碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 1,055,000 | $1.37 億 | 3.2% | +106,800+11.3% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 430,000 | $1.25 億 | 2.9% | +430,000 | 新進 | 歷史 |
| UHSUniversal Health Services Inc | CL B | 825,600 | $1.16 億 | 2.7% | +825,600 | 新進 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 727,541 | $1.16 億 | 2.7% | +409,241+128.6% | 加碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 5,150,000 | $1.04 億 | 2.4% | +926,900+21.9% | 加碼 | 歷史 |
| ACHCAcadia Healthcare Company, Inc. | COM | 1,165,000 | $9,590 萬 | 2.2% | −224,200−16.1% | 減碼 | 歷史 |
| SGRYSurgery Partners, Inc. | Stock | 3,112,000 | $8,670 萬 | 2.0% | +2,844,400+1,062.9% | 加碼 | 歷史 |
| DXCMDexcom Inc | COM | 756,800 | $8,570 萬 | 2.0% | +289,200+61.8% | 加碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 1,200,000 | $8,136 萬 | 1.9% | +636,800+113.1% | 加碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 217,000 | $7,939 萬 | 1.9% | −790,000−78.5% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 1,615,400 | $7,746 萬 | 1.8% | +986,700+156.9% | 加碼 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 3,275,000 | $7,267 萬 | 1.7% | +675,000+26.0% | 加碼 | – |
| NTRANatera, Inc. | COM | 1,798,900 | $7,226 萬 | 1.7% | +63,900+3.7% | 加碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 3,824,800 | $6,950 萬 | 1.6% | +109,400+2.9% | 加碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 1,154,000 | $6,586 萬 | 1.5% | −925,100−44.5% | 減碼 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 3,990,000 | $6,564 萬 | 1.5% | +1,306,000+48.7% | 加碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 2,475,000 | $5,895 萬 | 1.4% | +153,800+6.6% | 加碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 299,000 | $5,875 萬 | 1.4% | −132,800−30.8% | 減碼 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 1,375,000 | $5,577 萬 | 1.3% | +119,626+9.5% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 670,000 | $5,168 萬 | 1.2% | −868,600−56.5% | 減碼 | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 172,000 | $4,967 萬 | 1.2% | −340,800−66.5% | 減碼 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 970,000 | $4,842 萬 | 1.1% | +970,000 | 新進 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 6,782,400 | $4,775 萬 | 1.1% | +1,368,000+25.3% | 加碼 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 2,240,400 | $4,331 萬 | 1.0% | +259,300+13.1% | 加碼 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 1,285,000 | $4,214 萬 | 1.0% | +1,285,000 | 新進 | 歷史 |
| ICLRIcon PLC | COM | 215,000 | $4,176 萬 | 1.0% | +215,000 | 新進 | 歷史 |
| DGXQuest Diagnostics Inc | COM | 258,000 | $4,036 萬 | 0.9% | +258,000 | 新進 | 歷史 |
| BIOBio-Rad Laboratories, Inc. | CL A | 92,200 | $3,877 萬 | 0.9% | −52,600−36.3% | 減碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 4,599,998 | $3,781 萬 | 0.9% | +253,298+5.8% | 加碼 | – |
| THCTenet Healthcare Corp | COM NEW | 717,300 | $3,500 萬 | 0.8% | +717,300 | 新進 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 9,633,911 | $3,276 萬 | 0.8% | +9,633,911 | 新進 | 歷史 |
| BNTXBioNTech SE | SPONSORED ADS | 215,400 | $3,236 萬 | 0.8% | +215,400 | 新進 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 1,565,000 | $3,028 萬 | 0.7% | +522,294+50.1% | 加碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,527,087 | $2,989 萬 | 0.7% | +1,527,087 | 新進 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 504,000 | $2,667 萬 | 0.6% | −898,500−64.1% | 減碼 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 1,755,000 | $2,597 萬 | 0.6% | +960,500+120.9% | 加碼 | 歷史 |
| RXDXPrometheus Biosciences, Inc. | COM | 204,000 | $2,244 萬 | 0.5% | +204,000 | 新進 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 638,200 | $2,227 萬 | 0.5% | −360,900−36.1% | 減碼 | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 850,000 | $2,151 萬 | 0.5% | +850,000 | 新進 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,900,000 | $2,132 萬 | 0.5% | −6,800−0.4% | 減碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 1,492,000 | $2,071 萬 | 0.5% | +1,492,000 | 新進 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 420,700 | $1,928 萬 | 0.5% | +85,700+25.6% | 加碼 | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 1,126,000 | $1,846 萬 | 0.4% | −65,800−5.5% | 減碼 | 歷史 |
| CRBUCaribou Biosciences, Inc. | COM | 2,882,600 | $1,810 萬 | 0.4% | −290,000−9.1% | 減碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 838,407 | $1,795 萬 | 0.4% | +838,407 | 新進 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 2,432,400 | $1,773 萬 | 0.4% | −387,600−13.7% | 減碼 | 歷史 |
| NSTGNS Wind Down Co., Inc. | COM | 2,057,200 | $1,640 萬 | 0.4% | +1,359,000+194.6% | 加碼 | 歷史 |
| TWSTTwist Bioscience Corp | COM | 611,000 | $1,455 萬 | 0.3% | +611,000 | 新進 | 歷史 |
| BCABBioAtla, Inc. | COM | 1,260,000 | $1,040 萬 | 0.2% | +1,260,000 | 新進 | 歷史 |
| CMPXCompass Therapeutics, Inc. | COM | 2,000,000 | $1,006 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SGMOQSangamo Therapeutics, Inc | COM | 2,748,300 | $863.0 萬 | 0.2% | +387,500+16.4% | 加碼 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,028,200 | $755.7 萬 | 0.2% | +29,600+3.0% | 加碼 | 歷史 |
| KNTEKinnate Biopharma Inc. | COM | 1,212,700 | $739.7 萬 | 0.2% | +890.0% | 加碼 | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 743,600 | $708.7 萬 | 0.2% | +970+0.1% | 加碼 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 1,303,600 | $668.7 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 520,000 | $523.6 萬 | 0.1% | 00.0% | 不變 | – |
| LENZLENZ Therapeutics, Inc. | COM | 1,575,000 | $522.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 500,000 | $505.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $502.5 萬 | 0.1% | 00.0% | 不變 | – |
| EPIXESSA Pharma Inc. | COM NEW | 1,855,400 | $467.6 萬 | 0.1% | −604,600−24.6% | 減碼 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $399.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 900,000 | $323.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CYTCyteir Therapeutics, Inc. | COM | 1,795,800 | $296.3 萬 | 0.1% | −10,400−0.6% | 減碼 | 歷史 |
| CMAXCareMax, Inc. | COM CL A | 755,329 | $275.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| DNABSocial Capital Suvretta Holdings Corp. II | CLASS A ORD SHS | 200,000 | $201.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| DNADSocial Capital Suvretta Holdings Corp. IV | CLASS A ORD SHS | 200,000 | $201.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| SCYXScynexis Inc | COM NEW | 1,140,600 | $177.9 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| HYPRHyperfine, Inc. | COM CL A | 1,503,754 | $126.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| FATEFate Therapeutics Inc | COM | 104,653 | $105.6 萬 | <0.1% | +104,653 | 新進 | 歷史 |
| ZLABZai Lab Ltd | ADR | 31,309 | $96.1 萬 | <0.1% | −1,202,691−97.5% | 減碼 | 歷史 |
| COLLCollegium Pharmaceutical, Inc | COM | 37,898 | $87.9 萬 | <0.1% | +37,898 | 新進 | 歷史 |
| ACIUAC Immune SA | SHS | 325,400 | $66.4 萬 | <0.1% | +50,524+18.4% | 加碼 | 歷史 |
| Reunion Neuroscience Inc76134G103 | COM | 560,300 | $50.4 萬 | <0.1% | −34,900−5.9% | 減碼 | – |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 99,999 | $1.45 萬 | <0.1% | 00.0% | 不變 | – |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 57,770 | $5,199 | <0.1% | 00.0% | 不變 | – |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | – | $3.37 億 |
2022 年第 3 季之後清倉（30 檔）
2022 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 3 季股數 | 2022 年第 3 季市值 | 2022 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| BIIBBiogen Inc. | COM | 600,000 | $1.60 億 | 3.5% | 歷史 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 1,480,000 | $1.17 億 | 2.6% | – |
| HUMHumana Inc | Stock | 212,000 | $1.03 億 | 2.2% | 歷史 |
| ELVElevance Health, Inc. | Stock | 207,600 | $9,430 萬 | 2.1% | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 1,482,200 | $9,173 萬 | 2.0% | 歷史 |
| AVTRAvantor, Inc. | COM | 4,522,600 | $8,864 萬 | 1.9% | 歷史 |
| CTLTCatalent, Inc. | COM | 940,000 | $6,802 萬 | 1.5% | 歷史 |
| SGENSeagen Inc. | COM | 445,500 | $6,096 萬 | 1.3% | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 288,500 | $5,775 萬 | 1.3% | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 844,000 | $5,765 萬 | 1.3% | 歷史 |
| SYKStryker Corp | Stock | 184,700 | $3,741 萬 | 0.8% | 歷史 |
| CNCCentene Corp | Stock | 432,400 | $3,365 萬 | 0.7% | 歷史 |
| NGMNGM Biopharmaceuticals Inc | COM | 1,798,100 | $2,352 萬 | 0.5% | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,357,700 | $2,026 萬 | 0.4% | 歷史 |
| NKTXNkarta, Inc. | COM | 1,414,082 | $1,861 萬 | 0.4% | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 132,000 | $1,780 萬 | 0.4% | 歷史 |
| SIBNSI-BONE, Inc. | COM | 996,700 | $1,740 萬 | 0.4% | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 1,450,000 | $1,737 萬 | 0.4% | 歷史 |
| ATECAlphatec Holdings, Inc. | COM NEW | 1,715,000 | $1,499 萬 | 0.3% | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,382,900 | $1,325 萬 | 0.3% | 歷史 |
| TMDXTransMedics Group, Inc. | COM | 300,000 | $1,252 萬 | 0.3% | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 891,100 | $1,144 萬 | 0.2% | 歷史 |
| SPNESeaSpine Holdings Corp | COM | 2,010,000 | $1,142 萬 | 0.2% | 歷史 |
| ERASErasca, Inc. | COM | 982,500 | $766.4 萬 | 0.2% | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $501.0 萬 | 0.1% | – |
| TNGXTango Therapeutics, Inc. | COM | 813,700 | $294.6 萬 | 0.1% | 歷史 |
| ONCSOncosec Medical Inc | COM | 2,945,000 | $143.7 萬 | <0.1% | 歷史 |
| WGSGeneDx Holdings Corp. | COMMON STOCK | 950,000 | $83.4 萬 | <0.1% | 歷史 |
| PHASPhaseBio Pharmaceuticals Inc | COM | 4,361,365 | $76.8 萬 | <0.1% | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 430,000 | $69.2 萬 | <0.1% | 歷史 |